Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2012C010 Product name: TELAPREVIR ET TOUTES FORMES THERAPEUTIQUES EQUIVALENTES PROTEGEES PAR LE BREVET DE BASE, TELLES QUE LES SELS ET/OU SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES DU TELAPREVIR OU LES SOLVATES DE TELS SELS.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2012C/010
Type:
Certificate
SPC type:
Medical
Basic patent number:
019680404
Status:
Invalid
Publication number:
2012C010
1rst applicant's nationality:
Procedural language:
French

Marketing authorization

Marketing authorization number:
EU/1/11/720/001
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
19/09/2011
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
16/03/2012
First marketing authorization date:
19/09/2011
Grant date:
Activation date:
31/08/2021
BE Publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
SPC/SPC Extension Expiration (if granted and all annual fees paid):
Rejection date:
Withdrawal date:

Applicant

1

Name:
JANSSEN PHARMACEUTICA N.V.
Legal Form:
From:
13/04/2015
Address:
Turnhoutseweg 30, 2340, Beerse, Belgium (BE)
To:

2

Name:
VERTEX PHARMACEUTICALS INCORPORATED
Legal Form:
From:
13/04/2015
Address:
50 Northern Avenue, MA 002210, Boston, Massachusetts, United States (US)
To:
13/04/2015

Agent

Name:
FRENNET Pierre-Paul
Legal Form:
From:
16/03/2012
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:

Deed

Change of owner(s)

Change Kind / Decision Type:
Assignment
Deed number:
RC2015000902B
Registration date:
13/04/2015
License effective date:
License expiration date:
Scope of license:
Deed filer:
PLUCKER Guy
Bulletin edition number:
Text:
Country code:
Updated license number:
Terminated license number:

Removed pledgee

Name:
Address:

Changed pledgee

Name:
Address:

Removed usufructuary

Name:
Address:

Added usufructuary

Name:
Address:

Changed usufructuary

Name:
Address:
Filing date Document type Publication Type Document Description Number of pages File Type